The Cooper Companies, Inc. $COO Shares Sold by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. reduced its stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 61.9% in the 3rd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 10,060 shares of the medical device company’s stock after selling 16,321 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Cooper Companies were worth $690,000 at the end of the most recent reporting period.

Several other hedge funds have also bought and sold shares of COO. J.Safra Asset Management Corp increased its holdings in shares of Cooper Companies by 204.8% during the 2nd quarter. J.Safra Asset Management Corp now owns 506 shares of the medical device company’s stock valued at $36,000 after purchasing an additional 340 shares in the last quarter. CYBER HORNET ETFs LLC purchased a new position in Cooper Companies in the second quarter valued at $36,000. MUFG Securities EMEA plc acquired a new position in shares of Cooper Companies in the second quarter worth about $42,000. Assetmark Inc. raised its position in shares of Cooper Companies by 357.8% in the second quarter. Assetmark Inc. now owns 618 shares of the medical device company’s stock worth $44,000 after acquiring an additional 483 shares during the period. Finally, Quent Capital LLC purchased a new stake in shares of Cooper Companies during the 3rd quarter worth about $44,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Insider Buying and Selling

In related news, Director Lawrence Erik Kurzius bought 2,000 shares of the firm’s stock in a transaction that occurred on Wednesday, December 17th. The stock was purchased at an average cost of $82.50 per share, for a total transaction of $165,000.00. Following the completion of the acquisition, the director owned 7,777 shares in the company, valued at approximately $641,602.50. This trade represents a 34.62% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Maria Rivas purchased 1,000 shares of Cooper Companies stock in a transaction on Thursday, December 18th. The stock was bought at an average cost of $82.13 per share, for a total transaction of $82,130.00. Following the transaction, the director directly owned 11,141 shares in the company, valued at $915,010.33. This represents a 9.86% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders have bought a total of 16,014 shares of company stock worth $1,304,416 over the last three months. 1.98% of the stock is owned by insiders.

Analysts Set New Price Targets

Several equities analysts recently weighed in on COO shares. Morgan Stanley lifted their price target on Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a research note on Monday, December 8th. Piper Sandler reaffirmed an “overweight” rating and set a $94.00 target price (up from $83.00) on shares of Cooper Companies in a research note on Friday, December 5th. Stifel Nicolaus set a $95.00 target price on Cooper Companies and gave the company a “buy” rating in a research report on Friday, December 5th. Robert W. Baird boosted their price target on shares of Cooper Companies from $85.00 to $98.00 and gave the stock an “outperform” rating in a report on Friday, December 5th. Finally, Barclays set a $98.00 price objective on shares of Cooper Companies and gave the stock an “overweight” rating in a research report on Monday. Eight equities research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Cooper Companies has an average rating of “Hold” and an average price target of $90.85.

Cooper Companies Price Performance

Shares of COO stock opened at $80.37 on Friday. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.89 and a quick ratio of 1.13. The company has a market capitalization of $15.75 billion, a PE ratio of 42.75, a price-to-earnings-growth ratio of 2.30 and a beta of 1.03. The firm’s 50-day moving average is $80.95 and its two-hundred day moving average is $74.18. The Cooper Companies, Inc. has a 12 month low of $61.78 and a 12 month high of $99.54.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings data on Thursday, December 4th. The medical device company reported $1.15 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.04. Cooper Companies had a return on equity of 10.02% and a net margin of 9.16%.The firm had revenue of $1.07 billion during the quarter, compared to the consensus estimate of $1.06 billion. During the same period last year, the company earned $1.04 EPS. The company’s quarterly revenue was up 4.6% on a year-over-year basis. Cooper Companies has set its FY 2026 guidance at 4.450-4.600 EPS and its Q1 2026 guidance at 1.020-1.040 EPS. Analysts predict that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.